The nuclear matrix in pathology

Virchows Archiv

Volumn 435, Issue 4, 1999, Pages 391-399

  Bosman, Fred T ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Fibrillogranular network; Lamin; Nuclear matrix; Nucleolus; Nucleus

Indexed keywords

AUTOANTIBODY; HISTONE; LAMIN; NUCLEAR PROTEIN; NUCLEIC ACID; RIBOSOME RNA;

CELL NUCLEUS MATRIX; CELL NUCLEUS MEMBRANE; CELL ULTRASTRUCTURE; NUCLEOLUS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; RNA PROCESSING;

ANIMALS; HUMANS; MICROSCOPY, IMMUNOELECTRON; NUCLEAR MATRIX;

EID: 0032843569     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050416     Document Type: Review

References (58)

1. Abedi-Valugerdi M, Hu H, Moller G (1997) Mercury-induced renal immune complex deposits in young (NZB × NZW)F1 mice: characterization of antibodies/autoantibodies. Clin Exp Immunol 110:86-91
2. Ausma J, van Eys GJ, Broers JL, et al (1996) Nuclear lamin expression in chronic hibernating myocardium in man. J Mol Cell Cardiol 28:1297-1305
3. Barboro P, Alberti I, Sanna P, et al (1996) Changes in the cytoskeletal and nuclear matrix proteins in rat hepatocyte neoplastic nodules in their relation to the process of transformation. Exp Cell Res 225:315-327
4. Berezney R, Coffey DS (1974) Identification of a nuclear protein matrix. Biochem Biophys Res Commun 60:1410-1417
5. Berezney R, Mortillaro MJ, Ma H, Wei X, Samarabandu J (1995) The nuclear matrix: a structural milieu for genomic function. Int Rev Cytol [A] 162:1-65
6. Bestor TH (1998) Gene silencing. Methylation meets acetylation. Nature 393:311-312
7. Brito J, Biamonti G, Caporali R, Montecucco C (1994) Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases. J Immunol 153:2268-2277
8. Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS, Ramaekers FC (1993) Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol 143:211-220
9. Broers JL, Machiels BM, Kuijpers HJ, et al (1997) A- and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol 107:505-517
10. Chou YH, Yung BY (1995) Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin/B23. Biochem Biophys Res Commun 217:313-325
11. Derenzini M, Sirri V, Trere D, Ochs RL (1995) The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 73:497-502
12. Derenzini M, Trere D, Pession A, Montanaro L, Sirri V, Ochs RL (1998) Nucleolar function and size in cancer cells. Am J Pathol 152:1291-1297
13. Egan MJ, Crocker J (1992) Nucleolar organiser regions in pathology. Br J Cancer 65:1-7
14. Georgatos SD, Meier J, Simos G (1994) Lamins and lamin-associated proteins. Curr Opin Cell Biol 6:347-353
15. Getzenberg RH, Konety BR, Oeler TA, et al (1996) Bladder cancer-associated nuclear matrix proteins. Cancer Res 56:1690-1694
16. Getzenberg RH, Pienta KJ, Huang EY, Coffey DS (1991) Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res 51:6514-6520
17. Hadjiolov AA (1995) The nucleolus and ribosome biogenesis. Springer, Vienna New York, pp 1-267
18. Hang LM, Nakamura RM (1997) Current concepts and advances in clinical laboratory testing for autoimmune diseases. Crit Rev Clin Lab Sci 34:275-311
19. He D, Zeng C, Brinkley BR (1995) Nuclear matrix proteins as structural and functional components of the mitotic apparatus. Int Rev Cytol [B] 162:1-74
20. Hytiroglou P, Choi SW, Theise ND, Chaudhary N, Worman HJ, Thung SN (1993) The expression of nuclear lamins in human liver: an immunohistochemical study. Hum Pathol 24:169-172
21. Izzo RS, Pellecchia C (1998) Comparison of nuclear matrix protein composition in colon cancer and dysplasia. Scand J Gastroenterol 33:191-194
22. Jansen MP, Machiels BM, Hopman AH, et al (1997) Comparison of A- and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease. Histopathology 31:304-312
23. Jones PL, Veenstra GJC, Wade PA, et al (1998) Methylated DNA and MECP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191
24. Keesee SK, Briggman JV, Thill G, Wu YJ (1996) Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Exp 6:189-214
25. Konety BR, Nangia AK, Nguyen TS, et al (1998) Identification of nuclear matrix protein alterations associated with renal cell carcinoma. J Urol 159:1359-1363
26. Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM (1996) Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 98:1888-1896
27. Ladanyi M, Cavalchire G (1996) Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns. Diagn Mol Pathol 5:154-158
28. Ladanyi M, Cavalchire G (1996) Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site. Genes Chromosom Cancer 15:173-177
29. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356
30. Lakshmanan Y, Subong EN, Partin AW (1998) Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage. J Urol 159:1354-1358
31. Lazebnik YA, Takahashi A, Moir RD, et al (1995) Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 92:9042-9046
32. Lee B, Craft JE (1995) Molecular structure and function of autoantigens in systemic sclerosis. Int Rev Immunol 12:129-144
33. Lin F, Noyer CM, Ye Q, Courvalin JC, Worman HJ (1996) Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 23:57-61
34. Machiels BM, Ramaekers FC, Kuijpers HJ, Groenewoud JS, Oosterhuis JW, Looijenga LH (1997) Nuclear lamin expression in normal testis and testicular germ cell tumours of adolescents and adults. J Pathol 182:197-204
35. McCurdy DK, Bick M, Gatti RA, Naeim F (1992) Autoantibodies in systemic lupus erythematosus. Dis Markers 10:37-49
36. Moir RD, Spann TP, Goldman RD (1995) The dynamic properties and possible functions of nuclear lamins. Int Rev Cytol [B] 162:141-182
37. Mortillaro MJ, Blencowe BJ, Wei X, et al (1996) A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci USA 93:8253-8257
38. Muller PR, Meier R, Hirt A, et al (1994) Nuclear lamin expression reveals a surprisingly high growth fraction in childhood acute lymphoblastic leukemia cells. Leukemia 8:940-945
39. Nakayasu H, Berezney R (1991) Nuclear matrins: identification of the major nuclear matrix proteins. Proc Natl Acad Sci USA 88:10312-10316
40. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ (1994) Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106:193-199
41. Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT (1996) Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 178:48-52
42. Ofner D, Schmid KW (1996) Standardized AgNOR analysis: its usefulness in surgical oncology. Histochem Cell Biol 106:193-196
43. Partin AW, Getzenberg RH, CarMichael MJ, et al (1993) Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 53:744-746
44. Partin AW, Briggman JV, Subong EN, et al (1997) Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins. Urology 50:800-808
45. Provost TT, Talal N, Harley JB, Reichlin M, Alexander E (1988) The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch Dermatol 124:63-71
46. Rao L, Perez D, White E (1996) Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135:1441-1455
47. Replogle-Schwab R, Pienta KJ, Getzenberg RH (1996) The utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Exp 6:103-113
48. Roussel P, Hernandez-Verdun D (1994) Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity. Exp Cell Res 214:465-472
49. Samuel SK, Minish TM, Davie JR (1997) Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines. J Cell Biochem 66:9-15
50. Shelfo SW, Soloway MS (1997) The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder. World J Urol 15:107-111
51. van Driel R, Wansink DG, van Steensel B, Grande MA, Schul W, de Jong L (1995) Nuclear domains and the nuclear matrix. Int Rev Cytol [A] 162:151-189
52. Vazquez-Abad D, Rothfield NF (1995) Autoantibodies in systemic sclerosis. Int Rev Immunol 12:145-157
53. Versteege I, Sévenet N, Lange J, et al (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206
54. Vissers CJ, Flohil CC, de Jong AA, Dinjens WN, Bosman FT (1996) A new monoclonal antibody for specific immunocytochemical staining of nucleoli. Acta Histochem 98:113-121
55. von Muhlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323-358
56. Wade PA, Pruss D, Wolffe AP (1997) Histone acetylation: chromatin in action. Trends Biochem Sci 22:128-132
57. Wansink DG, van Driel R, de Jong L (1994) Organization of (pre)-mRNA metabolism in the cell nucleus. Mol Biol Rep 20:45-55
58. Weaver VM, Carson CE, Walker PR, et al (1996) Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J Cell Sci 109:45-56